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ABSTRACT
Objective To develop an Overall Pediatric Health 
Standard Set (OPH- SS) of outcome measures that 
captures what matters to young people and their families 
and recognising the biopsychosocial aspects of health 
for all children and adolescents regardless of health 
condition.
Design A modified Delphi process.
Setting The International Consortium for Health 
Outcomes Measurement convened an international 
Working Group (WG) comprised of 23 international 
experts from 12 countries in the field of paediatrics, 
family medicine, psychometrics as well as patient 
advisors. The WG participated in 11 video- conferences, 
through a modified Delphi process and 9 surveys 
between March 2018 and January 2020 consensus 
was reached on a final recommended health outcome 
standard set. By a literature review conducted in March 
2018, 1136 articles were screened for clinician and 
patient- reported or proxy- reported outcomes. Further, 
4315 clinical trials and 12 paediatric health surveys 
were scanned. Between November 2019 and January 
2020, the final standard set was endorsed by a patient 
validation (n=270) and a health professional (n=51) 
survey.
Results From a total of 63 identified outcomes, 
consensus was formed on a standard set of outcome 
measures that comprises 10 patient- reported outcomes, 
5 clinician- reported measures, and 6 case- mix variables. 
The four developmental age- specific packages (ie, 0–5, 
6–12, 13–17, 18–24 years) include either five or six 
measures with an average time for completion of 20 min.
Conclusions The OPH- SS is a starting point to drive 
value- based paediatric healthcare delivery from a global 
perspective for enhancing child and adolescent physical 
health and psychosocial well- being.
INTRODUCTION
It is a core value of any paediatric healthcare service 
to ensure that when a child leaves their service, they 
are as physically, mentally and socially healthy as 
possible.1 2 Value- based paediatric care (VBPC) 
requires health outcome measures to capture what 
matters most to young people and their families to 
enable this.3
Between March 2018 and January 2020, the 
International Consortium for Health Outcomes 
Measurement (ICHOM; www. ichom. org) 
convened a multidisciplinary Working Group (WG) 
to develop an Overall Pediatric Health Standard 
Set (OPH- SS). The OPH- SS comprises a minimum 
set of outcome measures using internationally 
accepted standardised measures for infants, chil-
dren and adolescents regardless of health condition. 
Collecting and using this information consistently 
as a part of care delivery will position caregivers 
to understand determinants of child and adoles-
cent well- being in a comprehensive way, promoting 
person- centred interventions and enhancing VBPC 
worldwide. Standardised and consistent outcomes 
What is already known on this topic?
 ► Value- based paediatric care needs health 
outcome measures that capture what matters 
to young people and their families.
 ► Comparable data on child development 
irrespective of health condition are rare and not 
always translatable across countries.
 ► There is a lack of an internationally accepted 
standard set of outcome measures that 
recognise the biopsychosocial aspects of health 
for all children and adolescents.
What this study adds?
 ► A consensus- based standard set of 15 health 
outcome measures for all young people from 
birth to 24 years of age, measuring 22 domains 
of physical, social and mental health.
 ► Four developmental age- specific packages 
made up of either five or six measures mainly 
patient- reported with average time of 20 min to 
complete.
 ► A starting point to drive value- based paediatric 
healthcare delivery from a global perspective.
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assessment for all young people is likely to promote future 
research and quality improvement collaborations, leading to 
benchmarking within and across organisations, and between 
disease types.
METHODS
The overall paediatric health Working Group
ICHOM established a WG of 23 international experts from eight 
high- income countries, three upper- middle- income countries and 
one lower- middle- income country (online supplemental eTable 
1). The WG included experts in Pediatrics, Family Medicine and 
Instrument Development fields across various professional back-
grounds (eg, medical doctors, occupational and physical ther-
apists). Additionally, two patient advisors (Australia and USA) 
who lead patient advocacy foundations were part of the WG. 
A Project Team (PT) guided the WG efforts and prepared the 
necessary materials. The project was launched in March 2018 
using an iterative process of 11 WG videoconferences and subse-
quent rounds of electronic surveys (online supplemental eFigure 
1).
Identifying health outcomes, health outcome measures and 
case-mix variables
To identify potential health outcome and corresponding outcome 
measures as well as case- mix variables for risk adjustment, the 
PT reviewed the literature and more than 4000 registered paedi-
atric clinical trials registered in the clinical trial database ( www. 
clinicaltrials. gov) (online supplemental eFigure 1), 12 paediatric 
health surveys, and the Patient- Reported Outcome Measure-
ment Information System (PROMIS) for outcome measures 
used in the paediatric population. The literature review was 
performed in March 2018 comprising 1136 articles with 580 
reviews (figure 1) (online supplemental eTable 2). First, health 
outcomes were identified by categorising the extracted measures 
from literature according to the topic/health outcome that they 
were considered to measure, for example, quality of life, devel-
opment, mental health and communication (online supplemental 
eTable 3). Overall, a total of 63 health outcomes (partly overlap-
ping) were identified (online supplemental eFigure 2 and eTables 
4–7). Second, a total of 104 measures of the agreed- upon health 
outcomes for inclusion were systematically evaluated to meet 
ICHOM’s tool selection criteria, for example, available free 
of charge, available in English, validated and reliable (online 
supplemental eTables 8 and 9). Third, the contents of the eligible 
26 tools were mapped to the consensus- based final 22 outcomes 
covered by the OPH- SS (eg, the PROMIS Pediatric Scale—Global 
health 7+2 is considered to measure quality of life, mood, 
mobility, fitness, pain and sleep). Finally, the tools were packaged 
along with clinician- reported measures and an ICHOM standard 
measure of survival, to ensure the highest outcome coverage by 
age range, using a minimum number of measures. Priority was 
given to continuity of instruments through the four OPH- SS age 
ranges and highest rates of outcome coverage (online supple-
mental eTables 10–12).
Case- mix variables identified by the literature review were 
extracted to enable meaningful comparisons of child and adoles-
cent health outcomes across treatment modalities and practices 
(online supplemental eTable 13).
Modified Delphi and consensus process
To reach consensus on health outcomes and outcome measures 
to be included in the OPH- SS, a modified Delphi process was 
employed (online supplemental eFigure 1).4 5 To capture addi-
tional patient perspectives beyond the WG level, an online 
survey was trialled via hospital networks with 88 parents and 
caregivers in Mexico. Respondents were asked to rank the 63 
identified health outcomes in accordance to the importance (on 
a 9- point Likert Scale) for their child/children’s well- being. This 
list was deemed to be comprehensive by 93% of parents/care-
givers and the survey results were presented to WG prior to the 
first Delphi round to inform outcome selection.
Following two voting rounds, only outcomes voted as ‘very 
important’ (ie, 7–9 points) by at least 80% of WG members 
were included. The outcomes that did not reach consensus were 
discussed during WG calls (2–4) in order to balance the request 
to develop a minimum but comprehensive standard set. In a 
third vote, the inconclusive outcomes were selected by a yes/
no vote with a 70% cut- off for inclusion. This cut- off applied 
to the selection of outcome measure packages, age range and 
case- mix variables. The final OPH- SS was approved by all WG 
members.
Consumer open review
Between November 2019 and January 2020, an electronic 
survey was sent to patients and professionals. While a sample of 
parents and caregivers of children and adolescents in Colombia, 
Singapore, the USA and the UK aged at least 18 years (online 
supplemental eTable 14) were asked to rank the importance of 
the preliminary OPH- SS outcomes, paediatric and/or outcome 
measurement professionals were asked to indicate agreement or 
disagreement with: the age- ranges defined by the OPH- SS, the 
inclusion of each of the 22 outcomes, the selected measures per 
outcome and age range and case- mix- variables. In both surveys, 
respondents had the opportunity to leave additional free text 
comments.
Figure 1 The flow- diagram of the literature search, conducted in 
March 2018 (including peer- reviewed articles from the last 10 years). 
*Only reviews were included due to the otherwise tremendous amount 
of results (n=20 740 and n=12 751, respectively).
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Ethical considerations
For the patient validation survey, an institutional review board 
(IRB) exemption review was obtained for each country (online 
supplemental eTable14).
RESULTS
In response to the latest debate on arbitrary age limits in 
paediatric care, which encourages including young adulthood, 
consensus was reached to include health outcome measures for 
newborns through 24 years of age (75%).6–8
The OPH-SS: health outcomes and measures
Through the modified Delphi process, consensus was reached to 
include 22 outcomes in the standard set ranging across the whole 
spectrum of biopsychosocial health (table 1) and are measured 
by 15 different tools (table 2):
 ► Five measures that are clinician- reported and often collected 
routinely in clinical practice: WHO Growth Charts—Early 
Years and School—Age Years versions, Visual Acuity Test—E- -
chart and Snellen- chart, Survival.
 ► Nine measures that are patient-/parent-/proxy- reported.
Table 2 Overview of the included outcomes, measures and case- mix variables (n=6), age- range specific
Age ranges Outcome Measures Respondent
0–5 years Survival, HRQoL, sleep, pain, mobility, 
development, communication, hearing, social 
functioning, vision, growth, nutrition, school 
attendance
ICHOM Standard Measure: Survival Clinician
CDC’s Developmental Milestones Checklist (available at: https://www.cdc.gov/
ncbddd/actearly/milestones/index.html)
Clinicia and patient/proxy
Visual Acuity Test—E- chart Clinician






Survival, HRQoL, sleep, pain, mobility, 
development communication, social 
functioning, vision, growth, nutrition, school 
attendance, cognition/intelligence, mood, 
mental health, coping, fitness
ICHOM Standard Measure: Survival Clinician
PROMIS Parent Proxy Scale V.1.0—Global Health 7+2 (available at: www.
healthmeasures.net)
Patient/proxy
Visual Acuity Test—Snellen- chart (E- chart where Snellen cannot be used) Clinician




PROMIS Parent Proxy Scale V.1.0—Cognitive Function 7a (available at: www.
healthmeasures.net)
13–17 years Survival, HRQoL, sleep, pain, mobility, 
development, communication, social 
functioning, growth, nutrition, school 
attendance, cognition/intelligence, mood, 
mental health, coping, fitness, self- esteem, 
self- efficacy
ICHOM Standard Measure: Survival Clinician




PROMIS Parent Proxy Scale V.1.0—Cognitive Function 7a (available at: www.
healthmeasures.net)
Patient/proxy
PROMIS Pediatric Scale V.1.0—Global Health 7+2 (available at: www.
healthmeasures.net)
Patient






Survival, HRQoL, sleep, pain, mobility, 
communication, social functioning, vision, 
hearing cognition/intelligence, mood, mental 
health, coping, fitness, self- esteem, self- 
efficacy
ICHOM Standard Measure: Survival Clinician
PROMIS Short Form V.1.0—Sleep Disturbance 4a (available at: www.
healthmeasures.net)
Patient
PROMIS Pool V.2.0—Sexual Function and Satisfaction: Screeners (available at: www.
healthmeasures.net)
Patient
PROMIS Short Form V.2.0—Cognitive Function 4a (available at: www.
healthmeasures.net)
Patient
AQoL- 8D (available at: http://www.aqol.com.au/choice-of-aqol-instrument/58.html) Patient
Case- mix variable     
Age
(ICHOM Standard Measure: Age)









(International Statistical Classification of Diseases and Related 
Health Problems (ICD))
Prior and current diagnosis of disease or no presence of diagnosis. Please list any 
prior and current conditions.
RESPONSE: ICD-10 or SNOMED- CT/None
Clinician
Parent education level
(ICHOM Standard Measure: Education (as defined by ISCED 
schooling levels)/Proxy measure for socioeconomic status on other 
ICHOM sets.
Please list highest level of education of either parent.
RESPONSE: None/Primary/Secondary/Tertiary
Patient and/or primary caregiver
Primary caregiver
(Non- standard measure)
Please state the primary caregiver (check all that apply).
RESPONSE: Mother or Father/Other family member/Self/Other
Patient and/or primary caregiver
Respondent
(Non- standard measure)
Who is providing this information about the patient?
RESPONSE: Mother or Father/Other family member/Self/Other
Patient and/or primary caregiver
These case- mix variables are recommended for all children, with an expectation that additional variables may need to be collected to allow context- specific benchmarking in some settings during 
implementation.
AQoL- 8D, Assessment of Quality of Life-8 Dimensions; CDC, Centers for Disease Control and Prevention; ICHOM, International Consortium for Health Outcomes Measurement; PROMIS, Patient- 
reported Outcomes Measurement Information System.
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 ► One that is both parent/proxy and clinician- reported, the 
Centers for Disease Control and Prevention Developmental 
Milestone Checklist.
The recommended age- group specific tool packages comprise 
between 5 and 6 instruments/measures, with 24–49 questions, 
taking between 15 and 40 min to complete.
Timepoints (in years) and frequency of measurements
At a minimum, measurements should be taken at the point of 
transition between developmental stages as defined by on the 
National Institute of Child Health and Human Development 
Pediatric Terminology9 (ages 6, 12, 18, 21 and where appro-
priate, age 24) (figure 2). The WG recommends optional annual 
measurements up to 5 years of age due to rapid development 
and then at ages 9 and 15 years. Since child and adolescent 
development varies independently of age, the use of the selected 
measures lends flexibility to an individual’s development.9 For 
example, if an adolescent is sexually active before the age of 18 
years, a clinician could use the PROMIS Pool v2.0- Sexual Func-
tion and Satisfaction—Screener earlier than the age of 18 years.
Case-mix variables
From a set of 30 case- mix variables identified (online supple-
mental eTable 13), 5 variables were included: age, sex, diagnosis, 
parent education level and primary caregiver and respondent 
(table 2). Since, several proxy- reported measures are included in 
the standard set, a sixth variable confirming the respondent (eg, 
mother/father, other family members, self, others) was included.
Consumer open review
Parents and professionals’ perspectives
A total of 270 parents or caregivers of children and adolescents 
participated in a survey. Most respondents had one child (41%) 
followed by two and three children (36% and 17%, respectively) 
with an equal sex distribution, representing the whole age- range 
covered by the OPH- SS (online supplemental eTable 15). At least 
86% of respondents ranked 20 of the 22 outcomes as important, 
with slightly fewer (76%) also deeming school attendance and 
sexual health as important (table 1). Almost all respondents 
(94%) agreed that this list captured all the important outcomes 
that matter most for paediatric patients.
In a concurrent survey of paediatrics health professionals 
from 14 countries (n=51) (online supplemental eTable 16), at 
least 88% or more of the respondents agreed with the proposed 
outcomes and case- mix variables (98% for mental and 92% for 
physical functioning) and over 94% agreed with the recom-
mended measurements for each OPH- SS age- range (table 1). 
Figure 2 Proposed timeline for collecting baseline, outcome and case- mix variables for each of the four specific developmental stage subsets.
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Comments from both parents and professionals who did not 
agree are presented in table 3 with comments from the WG.
Reference guide
In order to facilitate the adoption and implementation of the 
OPH- SS, a reference guide was developed by ICHOM (https:// 
connect. ichom. org/ standard- sets/ pediatric- overall- health/). 
It provides information and definitions for all variables, data 
sources and a recommended timeline for data collection.
DISCUSSION
The OPH- SS comprises 10 PROMs and 5 clinician- reported 
validated and reliable measures, using between 5 and 6 
measurements for each of the four developmental age- stages, 
with an average completion time of 20 min. Ultimately, 
healthcare should be ‘patient- centred’ and put ‘each patient 
in control of his or her own care’.10 Therefore, the OPH- SS 
is recommended for routine use in clinical practice to assess 
health outcomes and facilitate and empower young people and 
parents to make shared decisions about their care, with their 
caregivers.11 12
To allow meaningful comparisons across different settings and 
countries, six case- mix variables addressing demographic, clin-
ical and parental (or primary caregiver) risk factors are included. 
This is a multidisciplinary standard set of paediatric outcome 
measurements developed to measure the overall biopsychoso-
cial health and the well- being of anyone up to 24 years of age.8 
All measures are free of licensing fees and most are available in 
multiple languages to reduce barriers to uptake of the standard 
set internationally.
Table 3 Comments from respondents of the consumer open review survey who did not agree that the OPH- SS is complete with comments from 
the Working Group
Parents
(6% did not agree)
Professionals
(2%–12% did not agree)*
Included in 
OPH- SS (Yes/
No) Answers from the Working Group
Examples of specific questions 
contained in the included tools
Outcomes
Screen time No There is no standardised way to measure it yet
General happiness; joy Yes Included in PROMIS- General Health and 
AQoL- 8D
How often do you feel really sad?
How often do you have fun with friends?
How often do you feel happy?
How often do you feel pleasure?
Accessibility to quality healthcare No No outcome. It could be uptaken as a case- mix 
variable, but hard to measure in a standardised 
way worldwide.
Social interaction with peers and 
parents; social well- being; social 
environment in family and with 
friends
Social interactions with family, peers 
and adults should be defined by its 
own outcome separately from general 
functioning and development.
Yes Included in PROMIS- General Health and 
AQoL- 8D.
We tried to reduce the amount of tools and 
questions to answer in order to increase 
the uptake and feasibility of the OPH- SS. 
Therefore, it is not measured by a specific social 
interaction instrument.
How often do you feel socially excluded 
or left out?
How often do you have fun with friends?
How often do your parents listen to your 
ideas?
Does your health affect your relationship 
with your family?
How satisfying are your close relationships 
(family and friends)?
How much do you enjoy your close 
relationships (family and friends)? How 
often do you feel socially isolated?
Treatment in school No Not qualified to be included in a minimum set 
of health outcomes
Bullying Yes (?) It might be detected by questions in PROMIS- 
General Health and AQoL- 8D
How often do you feel socially excluded 
or left out?
How often do you have fun with friends? 
How often do you feel socially isolated?
Fine motor skills Yes Measured by CDC’s Developmental Milestones 
Checklist.
Makes or copies straight lines and circles; 
Pours, cuts with supervision, and mashes 
own food; Uses a fork and spoon and 
sometimes a table knife
Lifestyle factors, including addictions, 
should be included in the older age 
ranges.
No Not qualified to be included in a minimum set 
of health outcomes
Hearing should be assessed for all age 
ranges.
Yes/No It is not measured by any tool only for one age 




Yes Measured by Case- mix variable 'Diagnosis' ICD-10 or Snomed- CT
Genetics No Not feasible to measure worldwide, ethical 
aspects have to be considered
Home environment in terms of parents 
and access to food, healthcare and 
sanitation.
No Not qualified to be included in a minimum set 
of health outcomes
  Presence of complications during 
pregnancy as well as prematurity of 
the infant
No Not qualified to be included in a minimum set 
of health outcomes
  
*For more information about agreement of completeness from health professionals, see table 1.
AQoL- 8D, Assessment of Quality of Life-8 Dimensions; OPH- SS, Overall Pediatric Health Standard Set; PROMIS, Patient- Reported Outcome Measurement Information System.
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For the OPH- SS to drive VBPC, widespread implementa-
tion strategies to incorporate measures in routine clinical prac-
tice and existing workflows throughout various paediatric care 
settings will be critical. Meaningful, relevant and actionable 
comparative benchmarking practices need to be developed and 
refined. Implementation and adoption should allow healthcare 
comparison across different settings and countries to facilitating 
local and global improvements in paediatric care delivery and 
promoting international cross- cultural paediatric research.
Limitations
In order to minimise the burden of documentation and time to 
completion, the recommended measures cover several outcomes 
and comprise a minimum set of questions. The WG aimed to 
strike a balance between measuring each outcome using a specific 
instrument and risking double documentation or including 
instruments that measure broader concepts covering a variety of 
outcomes. Sum scores can be calculated for the included broader 
concepts (eg, quality of life, self- efficacy). While the global 
implementation of the OPH- SS allows further psychometric 
testing of the included measures for various populations, more 
comprehensive measures may be needed to increase validity 
and sensitivity for specific important outcomes. The feasibility 
of implementing the OPH- SS may vary between different coun-
tries and healthcare systems. As a result of varying technolog-
ical access, representation from low- income countries could 
not be included during the consensus process diminished as the 
WG process progressed. The ICHOM process is iterative and a 
Steering Committee, comprised of former WG members, will 
serve as a stewarding body to ensure that the OPH- SS remains 
up to date with the most current evidence and is revised in line 
with feedback received from implementation experiences across 
communities.
CONCLUSION
Based on an extensive literature review, assessment of clinical 
trials and registries, international patient input and paediatric 
expert consensus, a minimal set of 15 health outcome measures 
was developed. To our knowledge, this is the first set of paediatric 
outcome measurements not specific to any health condition but 
applicable to the overall biopsychosocial health and well- being 
of any infant, child or adolescent throughout all developmental 
stages from birth to 24 years of age. With the implementation of 
this set in daily clinical practice worldwide, care delivery teams 
should be increasingly accountable to promote well- being of 
individuals, with a subsequent understanding of the quality of 
care being delivered. Comprehensive evaluation of outcomes and 
discussion of the results with patients and parents will facilitate 
shared decision- making between families and their healthcare 
providers. Health literacy will also likely improve, ensuring that 
families will be sufficiently knowledgeable about the healthcare 
they receive, ultimately resulting in more equitable care delivery, 
globally. The next steps will be to implement the OPH- SS in 
the current clinical workflow, harmonising data collection with 
electronic health records and registries and developing strategies 
to provide the data back to clinical teams and patients, creating a 
meaningful process to drive value- based healthcare.
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